Shares of PureTech Health plc (OTCMKTS:PTCHF – Get Free Report) were up 3.4% during mid-day trading on Thursday . The stock traded as high as $1.83 and last traded at $1.83. Approximately 200 shares changed hands during trading, a decline of 97% from the average daily volume of 7,040 shares. The stock had previously closed at $1.77.
PureTech Health Trading Down 2.2 %
The stock has a 50-day simple moving average of $1.75 and a 200 day simple moving average of $1.90.
About PureTech Health
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
Further Reading
- Five stocks we like better than PureTech Health
- How to Read Stock Charts for Beginners
- MarketBeat Week in Review – 03/24 – 03/28
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- What is the Dow Jones Industrial Average (DJIA)?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
